Table 1. Characteristics of Taiwan liver transplant recipients from 1998 through 2012.
| N=2938 | N, Mean | %, SD |
|---|---|---|
| Sex | ||
| Male | 2068 | 70.39 |
| Female | 870 | 29.61 |
| Age (years)† | 46 | 17.68 |
| Age group | ||
| < 18 | 341 | 11.61 |
| ≧ 18 | 2597 | 88.39 |
| Follow-up time (years)† | 3.79 | 3.26 |
| <1 | 623 | 21.20 |
| 1-5 | 1466 | 49.90 |
| 5-10 | 667 | 22.70 |
| >10 | 182 | 6.19 |
| Person-years of follow-up | 14176 | |
| Pre-op cancer | ||
| Yes | 1440 | 49.01 |
| No | 1498 | 50.99 |
| Pre-op HCC | ||
| Yes | 1313 | 44.69 |
| No | 1625 | 55.31 |
| Liver cirrhosis | 2484 | 84.55 |
| Chronic hepatitis | ||
| Yes | 2761 | 93.98 |
| HBV-related | 1416 | 48.20 |
| HCV-related | 662 | 22.53 |
| Alcohol-related | 565 | 19.23 |
| No | 177 | 6.02 |
| Biliary atresia | ||
| Yes | 284 | 9.67 |
| No | 2654 | 90.33 |
| Wilson's disease | ||
| Yes | 35 | 1.19 |
| No | 2903 | 98.81 |
| Glycogen storage disease | ||
| Yes | 28 | 0.95 |
| No | 2910 | 99.05 |
| Urea cycle metabolism disorders | ||
| Yes | 16 | 0.54 |
| No | 2922 | 99.46 |
†
Values are mean and standard deviation. HCC, hepatocellular carcinoma.